Health Technology · Pharmaceuticals: Other · NSE: GRANULES · data 2026-10-09
Granules India Limited
Health check: Strong (7.6/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹815.25
Market cap
₹20,200 cr
P/E
30.3
P/B
—
ROE
13.5%
ROCE
17.9%
Debt / equity
0.3
Dividend yield
0.21%
1-year return
47.4%
52-week high
₹923.65
52-week low
₹529.85
Operating margin
17.2%
Growth
| Revenue (last 12 months) | ₹5,632 cr |
| Net profit (last 12 months) | ₹662 cr |
| Sales growth, 3 years (yearly) | 5.9% |
| Profit growth, 3 years (yearly) | 4.8% |
Chart patterns
- Double top — breakdown (key level ₹816)
- Descending triangle — forming (key level ₹816)
- Head and shoulders — breakdown (key level ₹816)
Similar companies
Cipla Ltd (CIPLA) · Aurobindo Pharma Ltd (AUROPHARMA) · Lupin Limited (LUPIN) · Sudeep Pharma Limited (SUDEEPPHRM) · Amrutanjan Health Care Limited (AMRUTANJAN)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open GRANULES in NSE Scanner →